NCT04809428

Brief Summary

Objective: To compare the vNOTES approach versus conventional laparoscopic approach to be used in elective bilateral salpingectomy for sterilisation as an opportunistic cancer prevention strategy. Study design: Prospective cohort, two-centred trial. Study population: All women aged over 18 who are planned to undergo for definitive surgical sterilisation regardless of parity with a non-prolapsed uterus. Primary outcomes: (1) Patient satisfaction (at 1st week and 1st month of the surgery) measured by The Patient Global Imression of Improvement (PGI-I), (2) Postoperative early pain (Visual Analog Score (VAS) at 6th and 24th hours of the surgery). Secondary outcomes: (1) Conversion to laparoscopy or laparotomy, (2) duration of the procedure, (3)total amount of analgesics used, (4) New-onset dyspareunia at first coitus measured by the Pain subdomain of Female Sexual Function Index (FSFI), (5) intraoperative complications, (6) postoperative complications

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 16, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 22, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2021

Completed
Last Updated

June 11, 2021

Status Verified

June 1, 2021

Enrollment Period

3 months

First QC Date

March 16, 2021

Last Update Submit

June 8, 2021

Conditions

Keywords

vNOTESScarless surgerycancer prevention

Outcome Measures

Primary Outcomes (4)

  • Patient satisfaction at first week

    Patient satisfaction will be measured with Patient Global Impression of Improvement (PGI-I). It is scored as: Very much better (1), Much better (2), A little better (3), No change (4), A little worse (5), Much worse (6), Very much worse (7). Patient reported as Very much better or much better will be regarded as satisfied.

    The first week after the surgical procedure

  • Patient satisfaction at first month

    Patient satisfaction will be measured with Patient Global Impression of Improvement (PGI-I). It is scored as: Very much better (1), Much better (2), A little better (3), No change (4), A little worse (5), Much worse (6), Very much worse (7). Patient reported as Very much better or much better will be regarded as satisfied.

    The first month after the surgical procedure

  • Postoperative pain at 6th hours

    Postoperative pain scores will be measured with using Visual Analogue Score (VAS) as self-reported by the participating women. The VAS scores range from 0= no pain to 10= worst imaginable pain.

    At the 6th hours after the surgical procedure

  • Postoperative pain at 24th hours

    Postoperative pain scores will be measured with using Visual Analogue Score (VAS) as self-reported by the participating women. The VAS scores range from 0= no pain to 10= worst imaginable pain.

    At the 24th hours after the surgical procedure

Secondary Outcomes (6)

  • Dyspareunia

    At 1st month after the surgical procedure

  • Duration of the surgical procedure

    Intraoperative

  • Conversion

    Intraoperative

  • Need of Analgesics

    Postoperative, 24 hours

  • Intraoperative complications

    Intraoperative

  • +1 more secondary outcomes

Study Arms (2)

vNOTES Salpingectomy

Elective bilateral salpingectomy by vaginal Natural Orifice Transluminal Endoscopic Surgery approach

Procedure: vNOTES salpingectomy

LS Salpingectomy

Elective bilateral salpingectomy by conventional laparoscopy

Procedure: Laparoscopic salpingectomy

Interventions

Surgical removal of both salpinx by vNOTES with using a 3-cm of posterior colpotomy and either glove port or Gel point V path. Colpotomy will be closed with using 2.0 rapid vicryl.

vNOTES Salpingectomy

Surgical removal of both salpinx by conventional laparoscopy in a standardised fashion: with using one 10-mm umbilical and two 5-mm lateral ports.

LS Salpingectomy

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women seeking for definitive surgical sterilization who prefers salpingectomy over tubal ligation due to its possible cancer risk reduction effect.

You may qualify if:

  • Women aged over 18 years regardless of parity with a non-prolapsed uterus
  • Patients who are indicated or seek for definitive surgical sterilisation
  • Patients who prefers salpingectomy over tubal ligation after considering its possible cancer prevention effect
  • Written informed consent obtained prior to surgery

You may not qualify if:

  • Any malignancy
  • Suspected rectovaginal endometriosis
  • History of pelvic inflammatory disease, pouch of Douglas abscess
  • Being Virgo or Pregnant
  • Failure to provide written informed consent prior to surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bakirkoy Sadi Konuk Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Sehit Prof Dr Ilhan Varank Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (5)

  • Kaya C, Alay I, Cengiz H, Baghaki S, Aslan O, Ekin M, Yasar L. Conventional Laparoscopy or Vaginally Assisted Natural Orifice Transluminal Endoscopic Surgery for Adnexal Pathologies: A Paired Sample Cross-Sectional Study. J Invest Surg. 2021 Nov;34(11):1185-1190. doi: 10.1080/08941939.2020.1789246. Epub 2020 Jul 7.

    PMID: 32633168BACKGROUND
  • Yassa M, Pulatoglu C. Patients' perceptions toward and the driving factors of decision-making for opportunistic bilateral salpingectomy at the time of cesarean section. Turk J Obstet Gynecol. 2020 Jun;17(2):115-122. doi: 10.4274/tjod.galenos.2020.12129. Epub 2020 Jul 29.

    PMID: 32850186BACKGROUND
  • Kaya C, Alay I, Yildiz S, Cengiz H, Afandi X, Yasar L. The Feasibility of Natural Orifice Transluminal Endoscopic Surgery in Gynecology Practice: Single-Surgeon Experience. Gynecol Minim Invasive Ther. 2020 Apr 28;9(2):69-73. doi: 10.4103/GMIT.GMIT_84_19. eCollection 2020 Apr-Jun.

    PMID: 32676283BACKGROUND
  • Baekelandt JF, De Mulder PA, Le Roy I, Mathieu C, Laenen A, Enzlin P, Weyers S, Mol BWJ, Bosteels JJA. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) adnexectomy for benign pathology compared with laparoscopic excision (NOTABLE): a protocol for a randomised controlled trial. BMJ Open. 2018 Jan 10;8(1):e018059. doi: 10.1136/bmjopen-2017-018059.

    PMID: 29326183BACKGROUND
  • Yassa M, Kaya C, Kalafat E, Tekin AB, Karakas S, Mutlu MA, Birol P, Tug N. The Comparison of Transvaginal Natural Orifice Transluminal Endoscopic Surgery and Conventional Laparoscopy in Opportunistic Bilateral Salpingectomy for Permanent Female Sterilization. J Minim Invasive Gynecol. 2022 Feb;29(2):257-264.e1. doi: 10.1016/j.jmig.2021.08.009. Epub 2021 Aug 16.

MeSH Terms

Conditions

Infertility, Female

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Study Officials

  • Cihan Kaya, MD

    Bakirkoy Sadi Konuk Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 16, 2021

First Posted

March 22, 2021

Study Start

February 12, 2021

Primary Completion

May 9, 2021

Study Completion

May 9, 2021

Last Updated

June 11, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share

Upon request, after the work is published

Shared Documents
CSR
Time Frame
Upon request, after the work is published, 5 years
Access Criteria
Upon request, after the work is published, 5 years

Locations